Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo.

ABSTRACT:

SUBMITTER: Guo Y 

PROVIDER: S-EPMC6168429 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature